Falling ill in Mexico has become a critical financial risk, as the cost of private medical care has surged by nearly 50% over the last three years. This spike—which encompasses everything from hospitalizations to specialized treatments—is placing direct pressure on the finances of Mexican households, according to data from Grupo Interesse.
The Mexican Association of Insurance Institutions reported that in 2025, insurers paid out more than 145 billion pesos in claims related to accidents and illnesses. This figure highlights the widespread increase in the cost of medical services across the country.
The financial burden falls primarily on citizens. The National Institute of Statistics and Geography (INEGI) noted that direct spending and unpaid household labor accounted for 45.4% of total health expenditure in 2024, a figure exceeding 1.12 trillion pesos.
Rising Poverty Driven by Medical Expenses
Out-of-pocket healthcare spending grew by 41.4% in real terms between 2018 and 2024, according to an analysis by México Evalúa based on the ENIGH survey. On average, families' quarterly expenditures rose from 1,135 pesos in 2018 to 1,605 pesos in 2024.
This increase has a regressive effect, as lower-income households must allocate a larger portion of their budgets to medical care. The cost crisis has pushed 287,000 households into poverty during the most recent period, representing a 60% increase compared to 2018.
Furthermore, 1.11 million households faced "catastrophic expenses" in 2024—medical costs so high they compromise their ability to survive. This represents a 64.5% surge compared to 2018 records.
Conditions such as cancer, diabetes, and cardiovascular diseases are the primary drivers of this economic pressure. Grupo Interesse explains that the chronic nature of these illnesses necessitates hospitalizations, specialized medications, and constant follow-up care, all of which drive costs upward.
The situation is further exacerbated by a lack of preventive care culture and low health insurance penetration. Delayed diagnoses increase both clinical complexity and the overall cost of treatment.
“Health must be managed as a financial risk,” warns the firm Grupo Interesse. Specialists suggest that the system must transition toward models that integrate prevention and cost control to ensure the sector's long-term sustainability.
